Applied dna abstracts selected for poster presentations showcasing lineadna and lineaivt platforms at upcoming mrna and car t industry conferences

Stony brook, ny / access newswire / september 23, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and present posters that underscore the company's flexible nucleic acid production solutions designed to meet critical unmet needs for the manufacture of advanced biotherapeutics: 4th annual mrna process development and cmc summit (boston, september 23-25) title: fast-tracking mrna medicines: a synthetic dna platform to optimize mrna production authors: atsuko sangria1, aaron chung2, and yuhua sun2 poster session date/time: wednesday, september 24, at 3:10 p.m. eastern poster: link also at the mrna conference, applied dna will feature its ivt discovery kit, a powerful platform for evaluating and optimizing in vitro transcription (ivt).
APDN Ratings Summary
APDN Quant Ranking